MANUSTROPIN 50 IU KIT. MAGNUS pharmaceuticals
MANUSTROPIN is a prescription product for the treatment of growth failure in children. Who do not make enough growth hormone on their own. This condition is called growth hormone deficiency (GHD)
Magnustropin should not be used to increase height in children after the growth plates have closed. Growth hormone should not be used in patients with diabetes who have certain types of diabetic retinopathy (eye problems).
Magnustropin should not be used in patients who have been recently diagnosed with cancer, with cancer, or who are being treated for cancer. Growth hormone deficiency can be caused by brain tumors. So, the presence of these brain tumors should be ruled out before treatment is started. Growth hormone should not be used if it is shown that a previous brain tumor has come back or is getting larger.
Growth hormone should not be used in patients who are critically ill because of surgery, trauma, or respiratory failure.
Growth hormone should not be used in children with Prader-Willi syndrome who are very overweight or have severe breathing problems.
Magnustropin should not be used by patients who have had an allergy or bad reaction to somatropin or any of the other ingredients in Magnustropin. In the event of an allergic reaction, seek prompt medical attention.
Some patients have developed diabetes mellitus while taking Magnustropin. Dosage of diabetes medicines may need to be adjusted during growth hormone treatment. Patients should be watched carefully if growth hormone is given along with glucocorticoid therapy and/or other drugs that are processed by the body in the same way.
In childhood cancer survivors, treatment with growth hormone may increase the risk of a new tumor, particularly certain benign brain tumors. This risk may be higher in patients who were treated with cranial radiation. Also, patients and their doctors should check regularly for skin changes.
Uses and dosage :
Magnustropin is designed for subcutaneous or intramuscular administration. One milligram of
Magnustropin is equivalent to approximately three International Units (3 IU). When used to treat adult
onset growth hormone deficiency, the drug is commonly applied at a dosage of .005/mg/kg per
day to .01mg/kg per day. This equates to roughly 1 IU to 3 IU per day for person of approximately
180-220 lbs. A long-term maintenance dosage is established after reviewing the patient’s IGF-1
levels and clinical response over time.
When used for physique- or performance-enhancing purposes, Magnustropin is usually
administered at a dosage between 1 IU and 6 IU /day (2-4 IU being most common). The drug
is commonly cycled in a similar manner to anabolic/androgenic steroids, with the length of intake
generally being between 6 weeks and 24 weeks. The anabolic effects of this drug are less
apparent than its lipolytic (fat loss) properties, and generally take longer periods of time and
higher doses to manifest themselves.
If you have Prader-Willi syndrome, call your doctor promptly if you develop signs of lung or breathing problems such as shortness of breath, coughing, or new or increased snoring. Rare cases of serious breathing problems have occurred in patients with Prader-Willi syndrome who use Magnustropin.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects: severe pain in your upper stomach spreading to your back, nausea and vomiting, fast heart rate; increased thirst, increased urination, hunger, dry mouth, fruity breath odour, drowsiness, dry skin, blurred vision, and weight loss; sudden and severe pain behind your eyes, vision changes; swelling in your head, face, hands, or feet; or
numbness or tingling in your wrist, hand, or fingers.
Less serious side effects may include: headache, feeling tired; redness, soreness, swelling, rash, itching, pain, or bruising where the medicine was injected; pain in your arms or legs, joint stiffness or pain; muscle pain; or cold symptoms such as stuffy nose, sneezing, sore throat.
Before using Magnustropin, tell your doctor if you use insulin or take oral (by mouth) medicine to treat diabetes. Magnustropin may affect blood sugar levels and you may need to adjust your dose of the diabetes medication. Do not change the dose of your diabetes medication without your doctor’s advice.
Tell your doctor if you use any type of steroid medicine such as cortisone, dexamethasone, methylprednisolone, prednisone, and others. Steroids can make Magnustropin less effective and your doses may need to be adjusted. Do not stop using a steroid suddenly. Follow your doctor’s instructions.
Tell your doctor about all other medications you use, especially cyclosporine (Gengraf, Neoral, Sandimmune), seizure medication, birth control pills, anabolic steroids, or hormone replacement medications for men or women.
This list is not complete and other drugs may interact with Magnustropin. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.